Publikation: Clinical update on cancer : molecular oncology of head and neck cancer
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically aggressive in nature. These cancers remain difficult to treat and treatment can cause severe, long-term side effects. For patients who are not cured by surgery and/or (chemo)radiotherapy, there are few effective treatment options. Targeted therapies and predictive biomarkers are urgently needed in order to improve the management and minimise the treatment toxicity, and to allow selection of patients who are likely to benefit from both nonselective and targeted therapies. This clinical update aims to provide an insight into the current understanding of the molecular pathogenesis of the disease, and explores the novel therapies under development and in clinical trials.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
SUH, Yae-Eun, Ivano AMELIO, Teresa GUERRERO URBANO, Mahvash TAVASSOLI, 2014. Clinical update on cancer : molecular oncology of head and neck cancer. In: Cell death & disease. Nature Publishing Group. 2014, 5, e1018. eISSN 2041-4889. Available under: doi: 10.1038/cddis.2013.548BibTex
@article{Suh2014-01-23Clini-57120, year={2014}, doi={10.1038/cddis.2013.548}, title={Clinical update on cancer : molecular oncology of head and neck cancer}, volume={5}, journal={Cell death & disease}, author={Suh, Yae-Eun and Amelio, Ivano and Guerrero Urbano, Teresa and Tavassoli, Mahvash}, note={Article Number: e1018} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57120"> <dc:contributor>Tavassoli, Mahvash</dc:contributor> <dc:language>eng</dc:language> <dc:contributor>Guerrero Urbano, Teresa</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-31T13:17:40Z</dc:date> <dcterms:issued>2014-01-23</dcterms:issued> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57120"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Amelio, Ivano</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:title>Clinical update on cancer : molecular oncology of head and neck cancer</dcterms:title> <dc:contributor>Suh, Yae-Eun</dc:contributor> <dc:rights>terms-of-use</dc:rights> <dc:creator>Suh, Yae-Eun</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-31T13:17:40Z</dcterms:available> <dc:creator>Amelio, Ivano</dc:creator> <dc:creator>Guerrero Urbano, Teresa</dc:creator> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57120/3/Amelio_2-1jzi3z4hlfp3p1.pdf"/> <dc:creator>Tavassoli, Mahvash</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:abstract xml:lang="eng">Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically aggressive in nature. These cancers remain difficult to treat and treatment can cause severe, long-term side effects. For patients who are not cured by surgery and/or (chemo)radiotherapy, there are few effective treatment options. Targeted therapies and predictive biomarkers are urgently needed in order to improve the management and minimise the treatment toxicity, and to allow selection of patients who are likely to benefit from both nonselective and targeted therapies. This clinical update aims to provide an insight into the current understanding of the molecular pathogenesis of the disease, and explores the novel therapies under development and in clinical trials.</dcterms:abstract> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57120/3/Amelio_2-1jzi3z4hlfp3p1.pdf"/> </rdf:Description> </rdf:RDF>